Pliant Therapeutics's total assets for Q1 2026 were $202.60M, a decrease of -10.05% from the previous quarter. PLRX total liabilities were $37.43M for the fiscal quarter, a -14.98% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.